New Releases from NCBI BookshelfFulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancer.​Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancer.

Post Content

​ 

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top